Financing
Debt Issuance Proceeds
Eli Lilly Debt Issuance Proceeds decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $6.46B to $0.00.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase indicates successful access to capital markets for expansion or refinancing, while a decrease may suggest a focus on deleveraging or limited market access.
Detailed definition
This metric tracks the total cash proceeds received from the issuance of long-term or short-term debt instruments. It re...
Peer comparison
Large-cap companies frequently issue debt to optimize their cost of capital; peers monitor this to maintain investment-grade credit ratings.
Metric ID:
debt_issuanceHistorical Data
12 periods
| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.41B | $0.00 | $0.00 | $0.00 | $0.00 | $3.96B | $500.00K | $6.45B | $4.96B | $6.46B | $6.71B | $0.00 |
| QoQ Change | — | -100.0% | — | — | — | — | -100.0% | >999% | -23.1% | +30.1% | +3.8% | -100.0% |
| YoY Change | — | — | — | -100.0% | — | — | — | +63.0% | — | +0.1% | +35.1% | -100.0% |
Range$0.00 – $6.71B
CAGR-100.0%
Avg YoY Growth-20.4%
Median YoY Growth+0.1%
Debt Issuance Proceeds at Other Companies
Frequently Asked Questions
- What is Eli Lilly's debt issuance proceeds?
- Eli Lilly (LLY) reported debt issuance proceeds of $0.00 in Q1 2026.
- How has Eli Lilly's debt issuance proceeds changed year-over-year?
- Eli Lilly's debt issuance proceeds decreased by 100.0% year-over-year, from $6.46B to $0.00.
- What does debt issuance proceeds mean?
- Cash received from taking on new debt.